Supplementary Figures S1-S7 from PLK1 Phosphorylates PAX3-FOXO1, the Inhibition of Which Triggers Regression of Alveolar Rhabdomyosarcoma

Authors:
  • VTVerena Thalhammer
    Verena Thalhammer
  • LLLaura A. Lopez-Garcia
    Laura A. Lopez-Garcia
  • DHDavid Herrero-Martin
    David Herrero-Martin
  • RHRegina Hecker
    Regina Hecker
  • DLDominik Laubscher
    Dominik Laubscher
  • MGMaria E. Gierisch
    Maria E. Gierisch
  • MWMarco Wachtel
    Marco Wachtel
  • PBPeter Bode
    Peter Bode
  • PNPaolo Nanni
    Paolo Nanni
  • BBBernd Blank
    Bernd Blank
  • EKEwa Koscielniak
    Ewa Koscielniak
  • BSBeat W. Schäfer
    Beat W. Schäfer

Abstract
Supplementary Figures S1-S7. Establishment of screening approach (S1); BI 2536 causes apoptosis and cell cycle arrest (S2); PLK1 phosphorylates PAX3-FOXO1 in vitro (S3); PLK4 is overexpressed in tumor biopsies (S4); PLK1 expression does not correlate with MIB1 expression in tumor biopsies (S5); PLK4 silencing reduces PAX3-FOXO1 activity (S6); PLK1 inhibition causes NMYC degradation (S7).